Join to View Full Profile
2323 N Lake DrMilwaukee, WI 53211
Phone+1 414-585-1448
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jia Xu, MD is a board certified pathologist in Milwaukee, Wisconsin. She is currently licensed to practice medicine in Wisconsin, District of Columbia, and Maryland.
Education & Training
Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Pathology-Anatomic and Clinical, 2015 - 2019
University of Florida College of MedicineClass of 2014
Certifications & Licensure
WI State Medical License 2022 - 2025
MD State Medical License 2019 - 2023
DC State Medical License 2019 - 2022
VA State Medical License 2019 - 2022
MA State Medical License 2014 - 2021- MA State Medical License 2018 - 2021
American Board of Pathology Pathology - Anatomic/Pathology - Clinical- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- 2 citationsAn atypical case of ectopic extramammary Paget disease presenting on the lateral neck.Priyank Sharma, Abigail Waldman, Jia Xu, F. Vleugels
JAAD Case Reports. 2019-09-25 - 14 citationsFrozen-Section Checklist Implementation Improves Quality and Patient Safety.Yigu Chen, Kevin R. Anderson, Jia Xu, Jeff Goldsmith, Yael K. Heher
American Journal of Clinical Pathology. 2019-05-03 - 6 citationsA Variant of the Histone-Binding Protein sNASP Contributes to Mouse Lupus.Jiyu Ju, Jia Xu, Yaoqiang Zhu, Xiaoyan Fu, Laurence Morel
Frontiers in Immunology. 2019-04-02
Press Mentions
Transcription Factor E2F4 Is an Indicator of Poor Prognosis and Is Related to Immune Infiltration in Hepatocellular CarcinomaJanuary 21st, 2021
Transcription Factor E2F4 Is an Indicator of Poor Prognosis and Is Related to Immune Infiltration in Hepatocellular CarcinomaDecember 26th, 2020
Singtel, NUS Develop New Approach for Quantum Key DistributionApril 23rd, 2019
